Masayoshi Nagata

associiate professor

Juntendo University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Masayoshi Nagata is an Associate Professor at Juntendo University in Japan. His research focuses on advanced urological oncology, particularly in prostate and renal cancers, as evidenced by his recent publications on predictive factors for recurrence after radical prostatectomy and the role of circulating tumor cells as prognostic biomarkers. His work also explores innovative surgical techniques and their implications for patient outcomes in complex cases.

Articles (8)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2020

Collaborators (2)

YAN LU

Juntendo University

JAPAN

View details

Tomoki Kimura

Juntendo University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masayoshi Nagata

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Prostate-Specific Antigen Decline Rate in the First Month Is a Timely Predictive Factor for Biochemical Recurrence After Robot-Assisted Radical Prostatectomy

The Detection and Negative Reversion of Circulating Tumor Cells as Prognostic Biomarkers for Metastatic Castration-Resistant Prostate Cancer with Bone Metastases Treated by Enzalutamide

Successful wound closure using fibrin glue for intractable neobladder‐urethral anastomosis leakage after radical cystectomy and neobladder reconstruction

Robot-Assisted Radical Cystectomy with Modified Vesica Ileale Padovana (VIP) Neobladder Configuration Using a Hybrid Approach: Initial Experience

T-Cell Receptor Repertoire as a Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma

Editorial Comment from Dr Nagata to Nomogram for predicting survival of renal cell carcinoma with tumor thrombus based on perioperative clinicopathological factors from a Chinese high‐volume center

Clinical use of expanded prostate cancer index composite-based health-related quality of life outcomes after robot-assisted radical prostatectomy for localized prostate cancer

Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer

Collaborators (2)

YAN LU

Tomoki Kimura

Make your next move.